Author

Winnie Namala

Observed name: W Namala

Observed institutions: MRC Clinical Trials Unit at UCL, Joint Clinical Research Centre, University College London, Medical Research Council

OpenAlex ID: A5108961586

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

2017 · Nicholas I Paton, Nicholas I Paton, et al. · The Lancet HIV · 80

Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

2018 · Seth C Inzaule, Raph L Hamers, et al. · The Lancet HIV · 78

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

2017 · James G Hakim, Jennifer Thompson, et al. · The Lancet Infectious Diseases · 41

Response to Nonnucleoside Reverse Transcriptase Inhibitor-Based Therapy in HIV-Infected Children with Perinatal Exposure to Single-Dose Nevirapine

2009 · Victor Musiime, Francis Ssali, et al. · AIDS Research and Human Retroviruses · 21

Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV

2018 · Felicity C Fitzgerald, Edouard Lhomme, et al. · The Journal of Infectious Diseases · 15

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

2018 · Jennifer A Thompson, Cissy Kityo, et al. · Clinical Infectious Diseases · 11

Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial

2024 · Hylke Waalewijn, Roeland E Wasmann, et al. · Journal of the Pediatric Infectious Diseases Society · 2

Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV

2025 · Lufina Tsirizani, Hylke Waalewijn, et al. · Antimicrobial Agents and Chemotherapy · 1

Antiretroviral Drug Resistance Mutations in HIV-1 Infected Ugandan Children Perinatally Exposed to Single Dose Nevirapine Following Virologic Failure to an NNRTI Based Regimen

2010 · Victor Musiime, Francis Ssali, et al.

Works count: 9

Citation count: 249

H-index: 6

I10-index: 6